Nanosonics Limited (ASX:NAN)

Market Cap	1.28B
Revenue (ttm)	198.63M
Net Income (ttm)	20.68M
Shares Out	303.63M
EPS (ttm)	0.07
PE Ratio	63.23
Forward PE	68.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	422,284
Average Volume	854,063
Open	4.130
Previous Close	4.120
Day's Range	4.100 - 4.230
52-Week Range	2.880 - 5.180
Beta	1.80
RSI	56.94
Earnings Date	Nov 19, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 470
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2025, Nanosonics's revenue was 198.63 million, an increase of 16.83% compared to the previous year's 170.01 million. Earnings were 20.68 million, an increase of 59.39%.